CMS' 2025 Final Rule included an increased payment for Intrinsic Therapeutics' Barricaid device, according to a Nov. 12 news release.
A live webcast of the presentation will be available on the Events and Presentations section of Bicara’s website at www.bicara.com. An archived replay of the webcast will be available for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback